Cardiovascular benefits of omega-3 fatty acids

Cardiovascular Research

Volumn 73, Issue 2, 2007, Pages 310-315

  Schacky, Clemens von ^a   Harris, William S ^b  

^a UNIVERSITY OF MUNICH   (Germany)

^b UNIVERSITY OF SOUTH DAKOTA   (United States)

Author keywords

Arrhythmia; Atherosclerosis; Coronary disease; Sudden death

Indexed keywords

ACETYLSALICYLIC ACID; ALPHA TOCOPHEROL; DOCOSAHEXAENOIC ACID; DOCOSAPENTAENOIC ACID; GLUCOSE; HEMOGLOBIN A1C; ICOSAPENTAENOIC ACID; LOW DENSITY LIPOPROTEIN; OMEGA 3 FATTY ACID; PRAVASTATIN; SIMVASTATIN;

CARDIOVASCULAR DISEASE; CARDIOVASCULAR FUNCTION; CARDIOVASCULAR RISK; CLINICAL TRIAL; CORONARY ARTERY DISEASE; DEPRESSION; DRUG ACTIVITY; ERYTHROCYTE; GLUCOSE HOMEOSTASIS; HEART DEATH; HEART INFARCTION; HUMAN; HYPERLIPIDEMIA; MEDICAL SOCIETY; NONHUMAN; PRIORITY JOURNAL; RECOMMENDED DRUG DOSE; REVIEW; RHEUMATOID ARTHRITIS; RISK FACTOR;

ANIMALS; CARDIOVASCULAR DISEASES; CARDIOVASCULAR SYSTEM; DEATH, SUDDEN, CARDIAC; DIETARY SUPPLEMENTS; ERYTHROCYTES; FATTY ACIDS, OMEGA-3; FISH OILS; HEALTH STATUS INDICATORS; HUMANS;

EID: 33845573084     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cardiores.2006.08.019     Document Type: Review

References (49)

1. Smith S.C., Allen J., Blair S.N., Bonow R.O., Brass L.M., Fonarow G.C., et al. AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update. Circulation 113 (2006) 2363-2372
2. De Backer G., Ambrosioni E., Borch-Johnsen K., Brotons C., Cifkova R., Dallongeville J., et al. European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and Other Societies on Cardiovascular Disease Prevention in Clinical Practice. Eur Heart J 24 (2003) 1601-1610
3. Priori S.G., Aliot E., Blomstrom-Lundqvist C., Bossaert L., Breithardt G., Brugada P., et al. European Society of Cardiology update of the guidelines on sudden cardiac death of the European Society of Cardiology. Eur Heart J 24 (2003) 13-15
4. Van der Werf F., Ardissino D., Betriu A., Cokkinos D.V., Falk E., Fox K.A., et al. Management of acute myocardial infarction in patients presenting with ST-segment elevation. The Task Force on the Management of Acute Myocardial Infarction of the European Society of Cardiology. Eur Heart J 24 (2003) 28-66
5. Ernährung G.H. Z Kardiol 94 Suppl 3 (2005) III/22-III/29
6. Hooper L., Thompson R.L., Harrison R.A., Summerbell C.D., Ness A.R., Moore H.J., et al. Risks and benefits of omega 3 fats for mortality, cardiovascular disease, and cancer: systematic review. Br Med J 332 (2006) 752-760
7. von Schacky C. The role of omega-3 fatty acids in cardiovascular disease. Curr Atheroscler Rep 5 (2003) 139-145
8. Harris W.S. Extending the cardiovascular benefits of omega-3 fatty acids. Curr Atheroscler Rep 7 (2005) 375-380
9. Siscovick D.S., Raghunathan T.E., King I., Weinmann S., Wicklund K.G., Albright J., et al. Dietary intake and cell membrane levels of long-chain n-3 polyunsaturated fatty acids and the risk of primary cardiac arrest. J Am Med Assoc 275 (1995) 836-837
10. Albert C.M., Campos H., Stampfer M.J., Ridker P.M., Manson J.E., Willett W.C., et al. Blood levels of long-chain n-3 fatty acids and the risk of sudden cardiac death. N Engl J Med 346 (2002) 1113-1118
11. Erkkilä A.T., Lehto S., Pyörälä K., and Uusitupa M.I.J. n-3 fatty acids and 5-y risks of death and cardiovascular disease events in patients with coronary artery disease. Am J Clin Nutr 78 (2003) 65-71
12. Mozaffarian D., Psaty B., Rimm E.B., Lemaitre R.N., Burke G.L., Lyles M.F., et al. Fish intake and risk of incident atrial fibrillation. Circulation 110 (2004) 368-373
13. Mozaffarian D., Geelen A., Brouwer I.A., Geleinjnse J.M., Zock P.L., and Katan M.B. Effect of fish oil on heart rate in humans: a meta-analysis of randomized controlled trials. Circulation 112 (2005) 1945-1952
14. Iso H., Rexrode K.M., Stampfer M.J., Manson J.E., Colditz G.A., Speizer F.E., et al. Intake of fish and omega-3 fatty acids and risk of stroke in women. J Am Med Assoc 285 (2001) 304-312
15. Sommerfiled T., and Hiatt W.R. Omega-3 fatty acids for intermittent claudication. Cochrane Database Syst Rev CD003833 (2004)
16. von Schacky C. Prophylaxis of atherosclerosis with marine omega-3 fatty acids - a comprehensive strategy. Ann Int Med 107 (1987) 890-899
17. O'Keefe Jr. J.H., Abuissa H., Sastre A., Steinhaus D.M., and Harris W.S. Effects of omega-3 fatty acids on resting heart rate, heart rate recovery after exercise, and heart rate variability in men with healed myocardial infarctions and depressed ejections fractions. Am J Cardiol 97 (2006) 1127-1130
18. Christensen J.H. n-3 fatty acids and the risk of sudden cardiac death. Emphasis on heart rate variability. Dan Med Bull 50 (2003) 347-367
19. Calo L., Bianconi L., Colivicchi F., Lamberti F., Loricchio M.L., de Ruvo E., et al. N-3 fatty acids for the prevention of atrial fibrillation after coronary bypass surgery. J Am Coll Cardiol 45 (2005) 1723-1728
20. Schrepf R., Limmer T., Weber P.C., Theisen K., and Sellmayer A. Immediate effects of n-3 fatty acid infusion on the induction of sustained ventricular tachycardia. Lancet 363 (2004) 1441-1442
21. Leaf A., Kang J.X., Xiao Y.F., and Billman G.E. Clinical prevention of sudden cardiac death by n-3 polyunsaturated fatty acids and mechanism of prevention of arrhythmias by n-3 fish oils. Circulation 107 (2003) 2646-2652
22. Leaf A., Albert C.M., Josephson M., Steinhaus D., Kluger J., Kang J.X., et al., for the Fatty Acid Antiarrhythmia Trial Investigators. Prevention of fatal arrhythmias in high-risk subjects by fish oil n-3 fatty acid intake. Circulation 112 (2005) 2762-2768
23. Raitt M.H., Connor W.E., Morris C., Kron J., Halperin B., Chuch S.S., et al. Fish oil supplementation and risk of ventricular tachycardia and ventricular fibrillation in patients with implantable defibrillators. A randomized controlled trial. J Am Med Assoc 293 (2005) 2884-2891
24. Thies F., Garry J.M., Yaqoob P., Rerkasem K., Williams J., Shearman C.P., et al. Association of n-3 polyunsaturated fatty acids with stability of atherosclerotic plaques: a randomised controlled trial. Lancet 361 (2003) 477-485
25. von Schacky C., Angerer P., Kothny W., Theisen K., and Mudra H. The effect of dietary omega-3 fatty acids on coronary atherosclerosis. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 130 (1999) 554-562
26. Eritsland J., Arnesen H., Gronseth K., Fjeld N.B., and Abdelnoor M. Effect of dietary supplementation with n-3 fatty acids on coronary artery bypass graft patency. Am J Cardiol 77 (1996) 31-36
27. von Schacky, C. A review of omega-3 ethyl esters for cardiovascular prevention and treatment of increased blood triglyceride levels. Vasc Health and Risk Management, 3, in press.
28. Morgan D.R., Dixon L.J., Hanratty C.G., El-Sherbeeny N., Hamilton P.B., McGrath L.T., et al. Effects of dietary omega-3 fatty acid supplementation on endothelium-dependent vasodilation in patients with chronic heart failure. Am J Cardiol 97 (2006) 547-551
29. He K., Rimm E.B., Merchant A., Rosner B.A., Stampfer M.J., Willett W.C., et al. Fish consumption and risk of stroke in men. J Am Med Assoc 288 (2002) 3130-3136
30. Burr M.L., Fehily A.M., Gilbert J.F., Rogers S., Holliday R.M., Sweetnam P.M., et al. Effects of changes in fat, fish, and fibre intakes on death and myocardial infarction: diet and reinfarction trial (DART). Lancet 2 (1989) 757-761
31. Ness A.R., Hughes J., Elwood P.C., Whitley E., Smith G.D., and Burr M.L. The long-term effect of dietary advice in men with coronary disease: follow-up of the Diet and Reinfarction trial. Eur J Clin Nutr 56 (2002) 512-518
32. The GISSI Prevenzione Group. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico. Lancet 354 (1999) 447-455 Erratum in: Lancet 2001;357:642
33. Marchioli R., Barzi F., Bomba E., Chieffo C., DiGregorio D.D.M.R., Franzosi M.G., et al. Early protection against sudden death by n-3 polyunsaturated fatty acids after myocardial infarction. Time-course analysis of the results of the Gruppo Italiano per lo Studio della Sopravvivenza nell ́Infarcto Miocardio (GISSI)-Prevenzione. Circulation 105 (2002) 1897-1903
34. Burr M.L., Ashfield-Watt P.A.L., Dunstan F.D.J., Fehily A.M., Breay P., Ashton T., et al. Lack of benefit of dietary advice to men with angina: results of a controlled trial. Eur J Clin Nutr 57 (2003) 193-200
35. Ness A.R., Ashfield-Watt P.A.L., Whiting J.M., Smith G.D., Hughes J., and Burr M.L. The long-term effect of dietary advice on the diet of men with angina: the diet and angina randomized trial. J Hum Nutr Diet 17 (2004) 117-119
36. Yokoyama M., Origasea H., and for the JELIS Investigators. Effects of eicosapentaenoic acid on cardiovascular events in Japanese patients with hypercholesterolemia: rationale, design, and baseline characteristics of the Japan EPA Lipid Intervention Study (JELIS). Am Heart J 146 (2003) 613-620 results reported as a "Late Breaking Clinical Trial" at American Heart Association Scientific Sessions 2005 in Dallas, TX, USA
37. Yusuf S., Sleight P., Pogue J., Bosch J., Davies R., and Dagenais G. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med 342 (2000) 145-153
38. Fox K.M., and EURopean trial On reduction of cardiac events with Perindopril in stable coronary artery disease Investigators. Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study). Lancet 362 (2003) 782-788
39. Baigent C., Keech A., Kearney P.M., Blackwell L., Buck G., Pollicino C., et al. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet 366 (2005) 1267-1278
40. Tavazzi L., Tognoni G., Franzosi M.G., Latini R., Maggioni A.P., Marchioli R., et al. Rationale and design of the GISSI heart failure trial: a large trial to assess the effects of n-3 polyunsaturated fatty acids and rosuvastatin in symptomatic congestive heart failure. Eur J Heart Fail 6 (2004) 635-641
41. He K., and Song Y. Risks and benefits of omega-3 fats: a few thoughts on systematic review. Br Med J 332 (2006) 915 e.g.
42. von Schacky C., Harris W.S., Mozaffarian D., and Kris-Etherton P.M. www.issfal.org.uk/HooperRebuttal.asp
43. Harris W.S., and von Schacky C. The omega-3 index: a new risk factor for death from coronary heart disease?. Prev Med 39 (2004) 212-220
44. Harris W.S., Sands S.A., Windor S.L., Ali H.A., Stevens T.L., Magalski A., et al. Omega-3 fatty acids in cardiac biopsies from heart transplantation patients: correlation with erythrocytes and response to supplementation. Circulation 110 (2004) 1645-1649
45. Iso H., et al., JPHC Study Group. Intake of fish and n3 fatty acids and risk of coronary heart disease among Japanese: the Japan Public Health Center-based (JPHC) study cohort I. Circulation 113 (2006) 195-202
46. Kon K., Ando S., Waki H., Yukawa H., and Shibata H. Correlation of dietary food intakes and serum fatty acids in urban senior citizens. J Nutr Health Aging 3 (1999) 34-41
47. Moore M.J., Glover B.M., McCann C.J., Cromie N.A., Ferguson P., Catnesy D.C., et al. Demographic and temporal trends in out of hospital sudden cardiac death in Belfast. Heart 92 (2006) 311-315
48. Kremer J.M. n-3 fatty acid supplements in rheumatoid arthritis. Am J Clin Nutr 71 1 Suppl (2000) 349S-351S
49. Sontrop J., and Campell M.K. Omega-3 polyunsaturated fatty acids and depression: a review of the evidence and a methodological critique. Prev Med 42 (2006) 4-13